Reuters logo
BRIEF-Biotec Pharmacon says Woulgan will be listed on UK Drug Tariff
2017年10月19日 / 晚上7点32分 / 1 个月前

BRIEF-Biotec Pharmacon says Woulgan will be listed on UK Drug Tariff

Oct 19 (Reuters) - Biotec Pharmacon ASA

* Says its wholly owned subsidiary Biotec BetaGlucans received feedback from NHS that Woulgan, a wound treatment product, will be listed on UK Drug Tariff from January 2018

* Says will focus its efforts on a successful launch in January 2018

* Says seeks to establish a portfolio of advanced wound care products based on the company’s proprietary beta-glucan technology Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below